IL10 and myeloid sarcoma: Conversely, IL-10, an inhibitory cytokine that is reduced in MS patients, increased with the administration of probiotics in 10 animal studies (monostrain in 6 and mixture in 4 studies) and 2 human studies, which may help improve MS symptoms [26,29–32,34,35,37,38,41,43,45].